Peripheral T-cell Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Peripheral T-cell Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 clinical trial evaluating alefacept in relapsed or refractory cutaneous T-cell lymphoma and peripheral T-cell non-Hodgkin's lymphoma…
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating the S0350 combination chemotherapy regimen in newly diagnosed stage II-IV peripheral T-cell non-Hodgkin lymphoma ha…
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL) [Phase 1, Phase 2]
Phase 1/2 study evaluating the combination of lenalidomide, vorinostat, and dexamethasone in relapsed Peripheral T-Cell Non-Hodgkin's Lympho…